In 2017, former FDA Commissioner Scott Gottlieb pushed back the agency’s deadline to start reviewing e-cigarettes from 2018 to 2022. A federal judge ruled in May that the FDA neglected its duty when it decided to postpone its review and ordered the agency to begin its review, according to CNBC.
“I firmly believe that many aspects of the youth vaping epidemic could have been addressed if the FDA had moved forward with reviewing all e-cigarettes on the market when it first had the chance two years ago,” said Frank Pallone Jr., D-N.J., during a House Energy and Commerce subcommittee hearing Sept. 25.
The subcommittee held the meeting, titled “Sounding the Alarm: The Public Health Threats of E-Cigarettes,” to discuss a vaping illness that has affected at least 530 people and killed at least ten.
Read the full article here.
More articles on population health:
FDA launches criminal probe into vape-related deaths
CBS, WarnerMedia and Viacom will stop running e-cigarette ads
Child and mother mortality rates are falling globally — but not fast enough
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
